Amended Statement of Ownership (sc 13g/a)
February 05 2020 - 2:11PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)*
Conatus
Pharmaceuticals, Inc.
(Name of Issuer)
Common Stock
(Title of
Class of Securities)
20600T108
(CUSIP Number)
December 31, 2019
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to
designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☒ Rule 13d-1(c)
☐ Rule 13d-1(d)
|
*
|
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form
with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
|
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Page 1 of 22
CUSIP No. 20600T108
|
|
|
|
|
|
|
|
|
1.
|
|
Name of
Reporting Persons
MPM BioVentures IV-QP,
L.P.
|
|
2.
|
|
Check the Appropriate Box if a Member
of a Group (See Instructions)
(a) ☐ (b) ☒
|
|
3.
|
|
SEC USE ONLY
|
|
4.
|
|
Citizenship or Place of
Organization
Delaware
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
|
5.
|
|
Sole Voting Power
0
|
|
|
6.
|
|
Shared Voting Power
0
|
|
|
7.
|
|
Sole Dispositive Power
0
|
|
|
8.
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
9.
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
|
10.
|
|
Check if the Aggregate Amount in Row
(9) Excludes Certain Shares (See Instructions)
☐
|
|
11.
|
|
Percent of Class Represented by Amount
in Row (9)
0%
|
|
12.
|
|
Type of Reporting Person (See
Instructions)
PN
|
Page 2 of 22
CUSIP No. 20600T108
|
|
|
|
|
|
|
|
|
1.
|
|
Name of
Reporting Persons
MPM BioVentures IV GmbH & Co. Beteiligungs
KG
|
|
2.
|
|
Check the Appropriate Box if a Member
of a Group (See Instructions)
(a) ☐ (b) ☒
|
|
3.
|
|
SEC USE ONLY
|
|
4.
|
|
Citizenship or Place of
Organization
Germany
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
|
5.
|
|
Sole Voting Power
0
|
|
|
6.
|
|
Shared Voting Power
0
|
|
|
7.
|
|
Sole Dispositive Power
0
|
|
|
8.
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
9.
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
|
10.
|
|
Check if the Aggregate Amount in Row
(9) Excludes Certain Shares (See Instructions)
☐
|
|
11.
|
|
Percent of Class Represented by Amount
in Row (9)
0%
|
|
12.
|
|
Type of Reporting Person (See
Instructions)
PN
|
Page 3 of 22
CUSIP No. 20600T108
|
|
|
|
|
|
|
|
|
1.
|
|
Name of
Reporting Persons
MPM Asset Management Investors BV4 LLC
|
|
2.
|
|
Check the Appropriate Box if a Member
of a Group (See Instructions)
(a) ☐ (b) ☒
|
|
3.
|
|
SEC USE ONLY
|
|
4.
|
|
Citizenship or Place of
Organization
Delaware
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
|
5.
|
|
Sole Voting Power
0
|
|
|
6.
|
|
Shared Voting Power
0
|
|
|
7.
|
|
Sole Dispositive Power
0
|
|
|
8.
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
9.
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
|
10.
|
|
Check if the Aggregate Amount in Row
(9) Excludes Certain Shares (See Instructions)
☐
|
|
11.
|
|
Percent of Class Represented by Amount
in Row (9)
0%
|
|
12.
|
|
Type of Reporting Person (See
Instructions)
OO
|
Page 4 of 22
CUSIP No. 20600T108
|
|
|
|
|
|
|
|
|
1.
|
|
Name of
Reporting Persons
MPM BioVentures V, L.P.
|
|
2.
|
|
Check the Appropriate Box if a Member
of a Group (See Instructions)
(a) ☐ (b) ☒
|
|
3.
|
|
SEC USE ONLY
|
|
4.
|
|
Citizenship or Place of
Organization
Delaware
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
|
5.
|
|
Sole Voting Power
0
|
|
|
6.
|
|
Shared Voting Power
0
|
|
|
7.
|
|
Sole Dispositive Power
0
|
|
|
8.
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
9.
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
|
10.
|
|
Check if the Aggregate Amount in Row
(9) Excludes Certain Shares (See Instructions)
☐
|
|
11.
|
|
Percent of Class Represented by Amount
in Row (9)
0%
|
|
12.
|
|
Type of Reporting Person (See
Instructions)
PN
|
Page 5 of 22
CUSIP No. 20600T108
|
|
|
|
|
|
|
|
|
1.
|
|
Name of
Reporting Persons
MPM Asset Management Investors BV5 LLC
|
|
2.
|
|
Check the Appropriate Box if a Member
of a Group (See Instructions)
(a) ☐ (b) ☒
|
|
3.
|
|
SEC USE ONLY
|
|
4.
|
|
Citizenship or Place of
Organization
Delaware
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
|
5.
|
|
Sole Voting Power
0
|
|
|
6.
|
|
Shared Voting Power
0
|
|
|
7.
|
|
Sole Dispositive Power
0
|
|
|
8.
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
9.
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
|
10.
|
|
Check if the Aggregate Amount in Row
(9) Excludes Certain Shares (See Instructions)
☐
|
|
11.
|
|
Percent of Class Represented by Amount
in Row (9)
0%
|
|
12.
|
|
Type of Reporting Person (See
Instructions)
OO
|
Page 6 of 22
CUSIP No. 20600T108
|
|
|
|
|
|
|
|
|
1.
|
|
Name of
Reporting Persons
MPM Bio 2014 NVS Strategic Fund, L.P.
|
|
2.
|
|
Check the Appropriate Box if a Member
of a Group (See Instructions)
(a) ☐ (b) ☒
|
|
3.
|
|
SEC USE ONLY
|
|
4.
|
|
Citizenship or Place of
Organization
Bermuda
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
|
5.
|
|
Sole Voting Power
0
|
|
|
6.
|
|
Shared Voting Power
0
|
|
|
7.
|
|
Sole Dispositive Power
0
|
|
|
8.
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
9.
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
|
10.
|
|
Check if the Aggregate Amount in Row
(9) Excludes Certain Shares (See Instructions)
☐
|
|
11.
|
|
Percent of Class Represented by Amount
in Row (9)
0%
|
|
12.
|
|
Type of Reporting Person (See
Instructions)
PN
|
Page 7 of 22
CUSIP No. 20600T108
|
|
|
|
|
|
|
|
|
1.
|
|
Name of
Reporting Persons
MPM BioVentures IV GP LLC
|
|
2.
|
|
Check the Appropriate Box if a Member
of a Group (See Instructions)
(a) ☐ (b) ☒
|
|
3.
|
|
SEC USE ONLY
|
|
4.
|
|
Citizenship or Place of
Organization
Delaware
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
|
5.
|
|
Sole Voting Power
0
|
|
|
6.
|
|
Shared Voting Power
0
|
|
|
7.
|
|
Sole Dispositive Power
0
|
|
|
8.
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
9.
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
|
10.
|
|
Check if the Aggregate Amount in Row
(9) Excludes Certain Shares (See Instructions)
☐
|
|
11.
|
|
Percent of Class Represented by Amount
in Row (9)
0%
|
|
12.
|
|
Type of Reporting Person (See
Instructions)
OO
|
Page 8 of 22
CUSIP No. 20600T108
|
|
|
|
|
|
|
|
|
1.
|
|
Name of
Reporting Persons
MPM BioVentures IV LLC
|
|
2.
|
|
Check the Appropriate Box if a Member
of a Group (See Instructions)
(a) ☐ (b) ☒
|
|
3.
|
|
SEC USE ONLY
|
|
4.
|
|
Citizenship or Place of
Organization
Delaware
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
|
5.
|
|
Sole Voting Power
0
|
|
|
6.
|
|
Shared Voting Power
0
|
|
|
7.
|
|
Sole Dispositive Power
0
|
|
|
8.
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
9.
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
|
10.
|
|
Check if the Aggregate Amount in Row
(9) Excludes Certain Shares (See Instructions)
☐
|
|
11.
|
|
Percent of Class Represented by Amount
in Row (9)
0%
|
|
12.
|
|
Type of Reporting Person (See
Instructions)
OO
|
Page 9 of 22
CUSIP No. 20600T108
|
|
|
|
|
|
|
|
|
1.
|
|
Name of
Reporting Persons
MPM BioVentures V GP LLC
|
|
2.
|
|
Check the Appropriate Box if a Member
of a Group (See Instructions)
(a) ☐ (b) ☒
|
|
3.
|
|
SEC USE ONLY
|
|
4.
|
|
Citizenship or Place of
Organization
Delaware
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
|
5.
|
|
Sole Voting Power
0
|
|
|
6.
|
|
Shared Voting Power
0
|
|
|
7.
|
|
Sole Dispositive Power
0
|
|
|
8.
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
9.
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
|
10.
|
|
Check if the Aggregate Amount in Row
(9) Excludes Certain Shares (See Instructions)
☐
|
|
11.
|
|
Percent of Class Represented by Amount
in Row (9)
0%
|
|
12.
|
|
Type of Reporting Person (See
Instructions)
OO
|
Page 10 of 22
CUSIP No. 20600T108
|
|
|
|
|
|
|
|
|
1.
|
|
Name of
Reporting Persons
MPM BioVentures V LLC
|
|
2.
|
|
Check the Appropriate Box if a Member
of a Group (See Instructions)
(a) ☐ (b) ☒
|
|
3.
|
|
SEC USE ONLY
|
|
4.
|
|
Citizenship or Place of
Organization
Delaware
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
|
5.
|
|
Sole Voting Power
0
|
|
|
6.
|
|
Shared Voting Power
0
|
|
|
7.
|
|
Sole Dispositive Power
0
|
|
|
8.
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
9.
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
|
10.
|
|
Check if the Aggregate Amount in Row
(9) Excludes Certain Shares (See Instructions)
☐
|
|
11.
|
|
Percent of Class Represented by Amount
in Row (9)
0%
|
|
12.
|
|
Type of Reporting Person (See
Instructions)
OO
|
Page 11 of 22
CUSIP No. 20600T108
|
|
|
|
|
|
|
|
|
1.
|
|
Name of
Reporting Persons
MPM BioVentures 2014 NVS Strategic Fund GP LLC
|
|
2.
|
|
Check the Appropriate Box if a Member
of a Group (See Instructions)
(a) ☐ (b) ☒
|
|
3.
|
|
SEC USE ONLY
|
|
4.
|
|
Citizenship or Place of
Organization
Delaware
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
|
5.
|
|
Sole Voting Power
0
|
|
|
6.
|
|
Shared Voting Power
0
|
|
|
7.
|
|
Sole Dispositive Power
0
|
|
|
8.
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
9.
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
|
10.
|
|
Check if the Aggregate Amount in Row
(9) Excludes Certain Shares (See Instructions)
☐
|
|
11.
|
|
Percent of Class Represented by Amount
in Row (9)
0%
|
|
12.
|
|
Type of Reporting Person (See
Instructions)
OO
|
Page 12 of 22
CUSIP No. 20600T108
|
|
|
|
|
|
|
|
|
1.
|
|
Name of
Reporting Persons
MPM BioVentures 2014 LLC
|
|
2.
|
|
Check the Appropriate Box if a Member
of a Group (See Instructions)
(a) ☐ (b) ☒
|
|
3.
|
|
SEC USE ONLY
|
|
4.
|
|
Citizenship or Place of
Organization
Delaware
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
|
5.
|
|
Sole Voting Power
0
|
|
|
6.
|
|
Shared Voting Power
0
|
|
|
7.
|
|
Sole Dispositive Power
0
|
|
|
8.
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
9.
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
|
10.
|
|
Check if the Aggregate Amount in Row
(9) Excludes Certain Shares (See Instructions)
☐
|
|
11.
|
|
Percent of Class Represented by Amount
in Row (9)
0%
|
|
12.
|
|
Type of Reporting Person (See
Instructions)
OO
|
Page 13 of 22
CUSIP No. 20600T108
|
|
|
|
|
|
|
|
|
1.
|
|
Name of
Reporting Persons
Luke Evnin
|
|
2.
|
|
Check the Appropriate Box if a Member
of a Group (See Instructions)
(a) ☐ (b) ☒
|
|
3.
|
|
SEC USE ONLY
|
|
4.
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
|
5.
|
|
Sole Voting Power
0
|
|
|
6.
|
|
Shared Voting Power
0
|
|
|
7.
|
|
Sole Dispositive Power
0
|
|
|
8.
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
9.
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
|
10.
|
|
Check if the Aggregate Amount in Row
(9) Excludes Certain Shares (See Instructions)
☐
|
|
11.
|
|
Percent of Class Represented by Amount
in Row (9)
0%
|
|
12.
|
|
Type of Reporting Person (See
Instructions)
IN
|
Page 14 of 22
CUSIP No. 20600T108
|
|
|
|
|
|
|
|
|
1.
|
|
Name of
Reporting Persons
Ansbert Gadicke
|
|
2.
|
|
Check the Appropriate Box if a Member
of a Group (See Instructions)
(a) ☐ (b) ☒
|
|
3.
|
|
SEC USE ONLY
|
|
4.
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
|
5.
|
|
Sole Voting Power
0
|
|
|
6.
|
|
Shared Voting Power
0
|
|
|
7.
|
|
Sole Dispositive Power
0
|
|
|
8.
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
9.
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
|
10.
|
|
Check if the Aggregate Amount in Row
(9) Excludes Certain Shares (See Instructions)
☐
|
|
11.
|
|
Percent of Class Represented by Amount
in Row (9)
0%
|
|
12.
|
|
Type of Reporting Person (See
Instructions)
IN
|
Page 15 of 22
CUSIP No. 20600T108
|
|
|
|
|
|
|
|
|
1.
|
|
Name of
Reporting Persons
Todd Foley
|
|
2.
|
|
Check the Appropriate Box if a Member
of a Group (See Instructions)
(a) ☐ (b) ☒
|
|
3.
|
|
SEC USE ONLY
|
|
4.
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
|
5.
|
|
Sole Voting Power
0
|
|
|
6.
|
|
Shared Voting Power
0
|
|
|
7.
|
|
Sole Dispositive Power
0
|
|
|
8.
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
9.
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
|
10.
|
|
Check if the Aggregate Amount in Row
(9) Excludes Certain Shares (See Instructions)
☐
|
|
11.
|
|
Percent of Class Represented by Amount
in Row (9)
0%
|
|
12.
|
|
Type of Reporting Person (See
Instructions)
IN
|
Page 16 of 22
Item 1.
Conatus Pharmaceuticals, Inc.
|
|
(b)
|
Address of Issuer’s Principal Executive Offices
|
16745 West Bernardo Drive, Suite 200
San Diego, CA 92127
Item 2.
|
|
(a)
|
Name of Person Filing
|
MPM BioVentures IV-QP, L.P.
MPM BioVentures IV GmbH & Co. Beteiligungs KG
MPM Asset Management Investors BV4 LLC
MPM BioVentures V, L.P.
MPM
Asset Management Investors BV5 LLC
MPM BioVentures IV GP LLC
MPM BioVentures IV LLC
MPM
BioVentures V GP LLC
MPM BioVentures V LLC
MPM Bio 2014 NVS Strategic Fund, L.P.
MPM BioVentures 2014 NVS Strategic Fund GP LLC
MPM BioVentures 2014 LLC
Luke
Evnin
Ansbert Gadicke
Todd Foley
|
|
(b)
|
Address of Principal Business Office or, if none, Residence
|
c/o MPM Capital LLC
450
Kendall Street
Cambridge, MA 02142
All entities were organized in Delaware except MPM BioVentures IV GmbH & Co. Beteiligungs KG, which was organized in Germany and MPM
Bio 2014 NVS Strategic Fund, L.P., which was organized in Bermuda. The individuals are all United States citizens.
|
|
(d)
|
Title of Class of Securities
|
Common Stock
20600T108
|
Item 3.
|
If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
|
Not applicable
Page 17 of 22
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MPM Entity
|
|
Shares
Held
Directly
|
|
|
Shares
Issuable
Upon
Exercise of
Warrants
Held
Directly
|
|
|
Sole
Voting
Power
|
|
|
Shared
Voting
Power
|
|
|
Sole
Dispositive
Power
|
|
|
Shared
Dispositive
Power
|
|
|
Beneficial
Ownership
|
|
|
Percentage
of Class
|
|
|
BV IV QP
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
%
|
|
BV KG
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
%
|
|
AM BV4
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
%
|
|
BV V
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
%
|
|
AM BV5
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
%
|
|
Bio 2014
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
%
|
|
BV IV GP
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
%
|
|
BV IV LLC
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
%
|
|
BV V GP
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
%
|
|
BV V LLC
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
%
|
|
Bio 2014 NVS
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
%
|
|
Bio 2014 LLC
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
%
|
|
Luke Evnin
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
%
|
|
Ansbert Gadicke
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
%
|
|
Todd Foley
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
%
|
|
Item 5.
|
Ownership of Five Percent or Less of a Class
|
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following ☒.
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person
|
Not Applicable
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the
Parent Holding Company or Control Person.
|
Not Applicable
|
Item 8.
|
Identification and Classification of Members of the Group
|
Not Applicable
|
Item 9.
|
Notice of Dissolution of a Group
|
Not Applicable
Not Applicable
Page 18 of 22
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: February 4, 2020
|
|
|
|
|
|
|
|
|
|
|
MPM BIOVENTURES IV-QP, L.P.
|
|
|
|
MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS
|
|
|
|
|
|
KG
|
|
By:
|
|
MPM BioVentures IV GP LLC,
|
|
|
|
|
|
|
|
|
|
its General Partner
|
|
|
|
By:
|
|
MPM BioVentures IV GP LLC,
|
|
|
|
|
|
|
|
|
|
in its capacity as the Managing Limited Partner
|
|
By:
|
|
MPM BioVentures IV LLC,
|
|
|
|
|
|
|
|
|
|
its Managing Member
|
|
|
|
By:
|
|
MPM BioVentures IV LLC,
|
|
|
|
|
|
|
|
|
|
its Managing Member
|
|
By:
|
|
/s/ Luke Evnin
|
|
|
|
|
|
|
|
|
|
Name: Luke Evnin
|
|
|
|
By:
|
|
/s/ Luke Evnin
|
|
|
|
Title: Member
|
|
|
|
|
|
Name: Luke Evnin
|
|
|
|
|
|
|
|
|
|
Title: Member
|
|
|
|
|
|
MPM ASSET MANAGEMENT INVESTORS BV4 LLC
|
|
|
|
MPM BIOVENTURES V, L.P.
|
|
|
|
|
|
|
|
By:
|
|
MPM BioVentures IV LLC
|
|
|
|
By:
|
|
MPM BioVentures V GP LLC,
|
|
|
|
its Manager
|
|
|
|
|
|
its General Partner
|
|
|
|
|
|
|
|
By:
|
|
/s/ Howard Rubin
|
|
|
|
By:
|
|
MPM BioVentures V LLC,
|
|
|
|
Name: Howard Rubin
|
|
|
|
|
|
its Managing Member
|
|
|
|
Title: Authorized Signatory
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Luke Evnin
|
|
|
|
|
|
|
|
|
|
Name: Luke Evnin
|
|
|
|
|
|
|
|
|
|
Title: Member
|
|
|
|
|
|
MPM ASSET MANAGEMENT INVESTORS BV5 LLC
|
|
|
|
MPM BIOVENTURES IV GP LLC
|
|
|
|
|
|
|
|
By:
|
|
MPM BioVentures V LLC
|
|
|
|
By:
|
|
MPM BioVentures IV LLC,
|
|
|
|
its Manager
|
|
|
|
|
|
its Managing Member
|
|
|
|
|
|
|
|
By:
|
|
/s/ Howard Rubin
|
|
|
|
|
|
|
|
|
|
Name: Howard Rubin
|
|
|
|
By:
|
|
/s/ Luke Evnin
|
|
|
|
Title: Authorized Signatory
|
|
|
|
Name:
|
|
Luke Evnin
|
|
|
|
|
|
|
|
Title:
|
|
Member
|
|
MPM BIOVENTURES IV LLC
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Luke Evnin
|
|
|
|
|
|
|
|
Name:
|
|
Luke Evnin
|
|
|
|
|
|
|
|
Title:
|
|
Member
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MPM BIOVENTURES V GP LLC
|
|
|
|
|
|
MPM BIOVENTURES V LLC
|
|
|
|
|
|
|
|
|
By:
|
|
MPM BioVentures V LLC,
|
|
|
|
|
|
By:
|
|
/s/ Luke Evnin
|
|
|
|
its Managing Member
|
|
|
|
|
|
Name:
|
|
Luke Evnin
|
|
|
|
|
|
|
|
|
|
Title:
|
|
Member
|
|
By:
|
|
/s/ Luke Evnin
|
|
|
|
|
|
|
|
|
|
Name:
|
|
Luke Evnin
|
|
|
|
|
|
|
|
|
|
Title:
|
|
Member
|
|
|
|
|
|
|
|
|
Page 19 of 22
|
|
|
|
|
|
|
|
|
|
|
MPM BIO 2014 NVS STRATEGIC FUND, L.P.
|
|
|
|
MPM BIOVENTURES 2014 NVS
|
|
|
|
|
|
|
|
STRATEGIC FUND GP LLC
|
|
By:
|
|
MPM BioVentures 2014 NVS Strategic
|
|
|
|
|
|
|
|
|
|
Fund GP LLC,
|
|
|
|
By:
|
|
MPM BioVentures 2014 LLC,
|
|
|
|
its General Partner
|
|
|
|
|
|
its Managing Member
|
|
|
|
|
|
|
|
By:
|
|
MPM BioVentures 2014 LLC,
|
|
|
|
|
|
|
|
|
|
its Managing Member
|
|
|
|
By:
|
|
/s/ Luke Evnin
|
|
|
|
|
|
|
|
Name:
|
|
Luke Evnin
|
|
By:
|
|
/s/ Luke Evnin
|
|
|
|
Title:
|
|
Managing Director
|
|
|
|
Name: Luke Evnin
|
|
|
|
|
|
|
|
|
|
Title: Managing Director
|
|
|
|
|
|
|
|
|
|
|
|
|
MPM BIOVENTURES 2014 LLC
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Luke Evnin
|
|
|
|
|
|
|
|
Name:
|
|
Luke Evnin
|
|
|
|
|
|
|
|
Title:
|
|
Managing Director
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Luke Evnin
|
|
|
|
By:
|
|
/s/ Ansbert Gadicke
|
|
|
|
Name: Luke Evnin
|
|
|
|
|
|
Name: Ansbert Gadicke
|
|
|
|
|
|
|
|
By:
|
|
/s/ Todd Foley
|
|
|
|
|
|
|
|
|
|
Name: Todd Foley
|
|
|
|
|
|
|
EXHIBITS
|
A:
|
Joint Filing Agreement
|
Page 20 of 22
Conatus Pharmaceuticals (NASDAQ:CNAT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Conatus Pharmaceuticals (NASDAQ:CNAT)
Historical Stock Chart
From Apr 2023 to Apr 2024
